Molecular Medicine in the Caribbean: The Way Forward

About the event…

Molecular Medicine in the Caribbean: The Way Forward

Sunday, 21 November 2021, 3.00pm-6.00pm

Online via ZOOM

This CME explores how molecular studies impact cancer treatment, reducing the need for chemotherapy, improving patient outcomes, incorporating biogenetics into treatment and more.  Topics include: Intro to Immunogenetics, Translational Immunogenetics and Cancer Medicine, Application in Cancer Treatment, case studies and more.

Speakers include Dr. Anesa Ahamad, Radiation Oncologist (USA) Dr. Edgardo Santos, Medical Oncologist (USA), local specialists.

CPE credit available.

Target: All health care professionals.

Sponsored by:

Registration: https://forms.gle/3SGYpRkuMJnrauHt5

Or email hhccmeevents@gmail.com

Or Call or WhatsApp 246-269-6183/ 246-253-9384

Payment:

Online:  https://secure.ticketpal.com/affiliate/hibiscushealthwebsite

Payment pick up (Barbados only) – add BDS$5.00

Call or text 246-253-9384

Bank to Bank transfer

More details: https://hibiscushealthcaribbean.com/ticketpal-payment/

Oncology – Targeted Therapies

We are pleased to announce Dr. Joanne Nicholls, Cancer Researcher, NY and Dr. Nadia Depeiza, Pathologist, Barbados to the programme! Sunday, 3 December 2023, 10am-3pm The Shell Suite, UWI, St. Michael  During the past three decades, the paradigm for cancer treatment has evolved from relatively non-specific cytotoxic agents to selective, mechanism-based therapeutics. Cancer chemotherapies were…

ECG Workshop

Sunday, 10 December 2023, 10am-4pm 3Ws Pavilion, UWI, St. Michael  A basic understanding of Electrocardiograms (ECGs) is necessary for all practitioners on the frontline of patient care. This ECG course provides an opportunity to learn a systematic approach to ECG interpretation for adult healthcare providers in conjunction with a practical “hands-on” session. The workshop will…

Oncology – Targeted Therapies

Sunday, 3 December 2023, 10am-3pm 3Ws Pavilion, UWI, St. Michael  During the past three decades, the paradigm for cancer treatment has evolved from relatively non-specific cytotoxic agents to selective, mechanism-based therapeutics. Cancer chemotherapies were initially identified through screens for compounds that killed rapidly dividing cells which remain a backbone of current treatment, but are limited…

Can’t find what you’re looking for? Use the search form to search the site.

Get new content delivered directly to your inbox.